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Human D~ dopamine receptor DNA was stably transfected into GH~Ct pituitary cells. Displacement of iodosulpiride binding in hD3 transfected 
cells (K, = 0.3 nM, B~ = 89 finol/mg protein) by dopaminergie l gands was indistinguishable from that ofhD3 receptors inC l io  cells. Only two 
clonal cell lines exhibited weak GppNHp.dependent shifts in ['~H]N.0437 binding, and these were used for functional assays. Neither arachidoni¢ 
acid metabolism, cAMP levels, inositol phosphate turnover, intraeellular calcium, or potassium currents were consintently affected by dopamine 
(1-10/aM). The paucity of responses indicates that human D~ receptors do not couple efficiently to these second messengers in GH4C~ cells. 
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1. INTRODUCTION 
To date five structural classes of human dopamine 
receptors, temaed D~-Ds, have been desctfbed [1-6]. 
Hydrophobicity analysis indicates that all of them have 
7 putative transmembrane sparming regions, and are 
thus homologous to previously described G-protein- 
linked receptors. D3 dopamine receptors have been im- 
plicated as a target for neuroleptic drugs [7,8]. This 
assertion isbased upon the affinity of atypical neurolep- 
tics, including clozapine, and drugs such as (+)-A J76 
and (+)-UH232, which have been suggested toact pref- 
erentially on dopamine 'autoreceptors' [9]. The localiza- 
tion of rat D3 mRNA and binding sites for the D3 
selective ligand [3H]quinpirole to limbic brain structures 
[10,11], which have been implicated in the etiology of 
schizophrenia, lend farther support o this view. 
Dopamine, acting on D,-like receptors, has robust 
inhibitory effects on neurones of the basal ganglia, in- 
cluding those in the ventral tegq'nental area and substan- 
tin nigra [12]. Although these brain regions also contain 
D3 mRNA [10], no description of a physiological re- 
sponse which can be unambiguously attributed to D3 
receptor activation has yet been described. This is partly 
because many brain regions may also contain D~. and/or 
D4 receptors, but also because few dopaminergie li-
gands such as quinpirole have an apparent selective 
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affinity for D3 receptors. G-protein-linked receptors can 
have both low and high affinity for agonists, depending 
upon their G-protein coupling state. Consequently, the 
selectivity of ligands such as quinpirole for D~ vs. D2 
receptors in CHO cells, in which only D.~ receptors are 
coupled ([7], Freedman ¢t al. unpublished observa- 
tions), may not necessarily reflect intrinsic differences 
in the agonist recognition sites between these receptors. 
Cloned rat D~ receptors can couple to several second 
messenger systems, including the inhibition of cAMP 
production, stimulation of arachidonic acid metabo. 
lism, and calcium mobilisation [13]. However, some of 
these ffects are dependent upon the expression system 
used, presumably due to the selective xpression of G- 
proteins in different cell lines [14]. Activation of cloned 
D, receptors may also have direct effects on ion chan- 
nels, including the activation of potassium channels as 
in GH4CI cells [15]. 
Although human D3 receptors have high homology 
to D2 and De receptors in the predicted transmcmbrane 
domains, these receptors have only 33 and 9_4% identity, 
respectively, in the third intracellular domain. This re- 
gion of G-protein-linked receptors i thought o be in- 
volved in coupling to effeetor mechanisms [16]. At least 
20 types of G-protein alpha; subunits, belonging to 4 
different structural c asses, have been described [17]. Of 
these, GH4C~ ceils are known to contain at least 8, some 
of'which, including G, and Go, are not typically tound 
in CHO cells ([18], G. Milligan, pers. commun.). The 
lack of functional coupling of D3 receptors in CHO cells 
may thus be due to the absence of appropriate G-pro- 
teins to which the receptor may couple. The aim of this 
study was to stably transfect human D3 receptors into 
GH4C~ cells, determine the affinities of dopaminergic 
ligands for these receptors, and study receptor thnction. 
Published by Elsevier Science Pttblishers B.V. 123 
Volume 312, number 2,3 FEBS LETTERS November 1992 
2. MATERIALS  AND METHODS 
2.1, Transfection procedure and binding assays 
Human D3 eDNA was subeloned into the mammalian expression 
vector, peDNAln¢o (Invitrogen), Stably transfected cell lines were 
obtained by transfecting this construct into GI'LC~ ceils by a standard 
~alclum phosphate method [19], Transfeeted cells were selected for 
their resistance tothe antibiotic G418 and assayed for their ability to 
bind [~-'51]iodosulpirid¢, GTP shifts were measured by examining the 
ability of GppNHp (100/aM) to reduce binding of the dopamine 
receptor agonist [~H]N-0437 (0.1 aM). 
2.2, Arachldonic acid, cAMP, and phosphatMyl inosttol (P1) h l,droly- 
sis 
The release of [~H]araehidonic acid was measured according to the 
methods of Kanterman etel, [20]. Briefly, GH~Ct cells were incubated 
with [~H] arachidonic acid (0.2 pCi/well) to isotopic equilibrium (18- 
24 h). Cells were washed twice with 25 mM HEPES DMEM supple- 
mented with 0.5% fatty acid-free bovine serum albumin solution. Ex- 
perimental gents were applied in a final volume of i ml and the 
reaction was allowed to proceed for 30 rain at 37"C. The reaction was 
stopped by removal of 750/el of the incubation medium, which was 
then centrifuged at 12,000 ×g for 3 min to remove non.adherent cells, 
500/tl of supernatant was removed, and released [~H]araehldonic acld 
was measured using liquid scintillation spectrophotomgtry, 
[3H]cAMP levels were measured in cells grown to confluence using 
a radlolmmunoassay (TRK 432 Amersham). The Pl turnover assay 
was performed in 24.well culture plates allowed to grow to just below 
confiuence, Cells were labelled overnight with' 5 /aC/ml of 
[aH]myoinositol. The next day cells were washed twice with 2 ml of 
HEPES-buffered Krebs' solution, pH "/,4. The plates were subse- 
quently incubated for 15 rain at 37=C. 10pl of LiCl (final concentra- 
tion 10 raM) was added to each well and 20 rain later test compounds 
were added in a volume of 10/~1, Assays were terminated after 30 rain 
by aspiration of the incubation media followed by addition of I ml 0.1 
M HCI. 15 rain later 750/el oF the extract was placed into tubes and 
extracted with chloroform/methanol (1:1), The mixture was snbse- 
quently centrifuged at 5"C for 10 min at 2,500 rpm. 750/el of the 
aqueous layer was loaded onto a l-ml Dowex column (AG I-xg). 
Columns were washed with 10 ml of 0.1 M formic acid and 5 ml of 
0.025 M ammonium fonnate/O.l M formic acid. The inositol mono- 
phosphate was then elated with 0,2 M ammonium tbrmate/0,1 M
formic acid into scintillation vials. Radioactivity was then determined 
using liquid scintillation speetrophotometry. CHO cells expressing the 
human MI muscarinic receptor were used a positive control. 
2.3, Calcium imag#~g 
Cells were loaded with the fluorescent indicator FURA-2 AM (2 
btM; 30 rain) in a saline containing (in raM): NaCi 150, KCI 3, HEPES 
10, glucose 10, sucrose 20, CaCi~ 2, and MgCI~ 2 at pH 7,4, Essentially, 
Table I
Comparative a~nities of various d~;~nline r ceptor ligands for the 
human D3 receptor expressed in GH4C~ cells vs, that of the D3 and 
D2 receptor expressed in CHO cells (Freedman et at. unpublished 
observations) 
Ligand hD3-GH~Ct hD3.CHO hD2-CHO 
Apomorphine 28 (22,34) 14 29 
Clorapine 55 (25,120) 74 33 
Dopamine 49 (26,91 ) 25 700 
Halopcridol 2.4 (1.4,4.0) 1.4 2.3 
(-)-Sulpirid¢ 5.5 (2.5,12.0) 8 5 
Quinpirole 9.1 (7.0,12) 16 580 
Data were fitted to a single-site model, and are expressed as K~ values 
(nM) :t: 95% confidence limits from 4-7 separate determi,tations. 
methods wcr¢ as previously described [21,22], The dye fluorescence at
540 am was measured uring alternate excitations at 340 and 380 nm 
wavelength light (0,1-1 Hz) using an MCID imaging system (Imaging 
Rcsearelt In¢,, Canada), 
2.4. Whole.cell patch.clamp recording 
Whole-cell patch-clamp recordings were made using 2 Mohm glass 
mierocleetrodcs which had been filled with (in raM); KCI 20, potas- 
sium aspartate 120, MgCl: 1, Mg-ATP 2, cyclic AMP 1, EGTA 10, 
HEPES 10, sodium creatine phosphate 5,ereatine phosphokinase 20
U/ml, Na-GTP 1, adjusts! to pl-I 7.4. Cells were perfused with an 
extracellular saline which contained (in raM); NaCl 135, glucose 10, 
HEPES 10, KCI 5, MgCI= 4, CaCl: 1, and tctrodotoxin 1/aM, pH 7.4 
at 22=C. Cells were voltage-clamped at -80 m~:, and following 1 s 
conditioning pulses to -100 or -120 inV, potassium currents were 
elicited by 100 ms voltage steps from -60 to + 100 mV (0.1 Hz). In the 
majority of experiments he series resistance was compensated for by 
90-98%, and all signals were leak subtracted. Whole-cell currents were 
captured on line, via a CED 1401 computer interface which wa.~ 
connected toan Axopateh 200 patch clamp amplifier (Axon Instru- 
ments), and were subse:2uently analyzed using CED voltage-clamp 
software (Cambridge Electronic Design). Activation and inactivation 
curves were fitted to Boltzman functions by least-squares analysis of 
variance using an iteratlv¢ procedure on a VAX computer with Re- 
search System 1 software (BBN Software Products Corporation). 
Data are expressed as the mean ± S.E,M. 
3. RESULTS AND DISCUSSION 
3.1. D3 receptor expression, ligand bbzding, and GTP 
shifts 
The affinity o f  [12~I]iodosulpiride was determined to 
be 0.34 nM (0.28-0.44), with a Bm.~ of  89 fmol /mg pro-  
tein (n = 3); min imal  specific b inding was detected in the 
contro l  cell line. Guan ine  nucleotide sensitivity o f  ag- 
onist  b ind ing was tested using [3I-I]N-0437 binding.  
Only  two c lone|  cell l ines exhibited weak GppNHp-  
dependent  shifts in agonist  b inding (ca. 10%). One of  
these clones, clone 18, was used for the funct ional  as- 
says. The affinities of dopaminergi¢ l igands for the re- 
ceptors expressed in these GH~C~ cells was indist in-  
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Fig. I. Displacement of0.2 nM [l:~i]iodosalpiride binding by haloperi- 
dol ([]), quinpirol¢ (m) and dopamine (o) in GH4C~ cells transfccted 
with human D~ receptors. Each data point represents file 
mean + S.E.M. of >4 seperate determinations. 
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Fig, 2, Coupling of human dopalnine r ceptors totile release of ara- 
chidonie acid. (A) Araehidonic a id release was potentiated by the 
activation of human D: receptors expressed in CHO cells following 
prctreatment wi h the calcium ionophor¢0 A23187. (B) In contrast to 
the hD2 cell ine, neither A23187 nor dopamine (10--1000 nM) affected 
the release of arachidonic a id from GH4CL c.¢lls which had been 
transfect~ with the human D~ receptor. 
gui:,h~ble from the hD3-CHO expression system (Table 
I, Fig. 1). As with the human D.a CHO cell line (Freed- 
man et el. unpublished observations) elozapine did not 
discriminate between D2 and D~ receptors. Those li- 
gands which were selective for the D3 receptor included 
the highly efficacious D= receptor agonists, dopamine 
and quinpirole. 
3.2. Lack of coupling to arachidonic acid, cAMP, PI 
turnover, or  intracellular calcium 
Forskolin (10/~M) produced an increase in cAMP 
levels in CHO cells transfected with human Dz(shor0 
receptors, from 0.19 __. 0.01 to 13.9 + 1.1 pmol per well. 
This was significantly inhibited by I and 10aM, but not 
0.01 #M, dopamin¢ (Fig. 2a). This inhibition was re- 
versed by pretreatment with haloperidol (1 aM,  data 
not shown). In the hD3-(3H4Ct c,¢11 line, forskolin also 
produced an increase in cAMP levels, from 0.08 +_. 0.03 
to 8.9 + 0.6l pmol per well. In contrast o the hD2- 
CHO cell line, dopamine (0.01-10aM) failed to reverse 
the forskolin stimulation (Fig. 2b). In a second series of 
experiments, dopamine (0.1 pM) faile~l to modify basal 
levels of cAMP in the hD3-GH4Cj cell line. 
Dopamine has been shown to stimulate the release of 
arachidonic acid from rat D2-CHO cells in the presence 
of either ATP or the calcium ionophore, A23187 [23]. 
Similarly, in the present study dopamine (0.01 to I aM) 
enhanced arachidinic acid release from hD2-transfectcd 
CHO cells in the presence of either A23187 (1 aM) or 
ATP (1 aM, data not shown). In contrast, in the hD3- 
GH4CI cells, dopamine (0.01-10 aM) did not enhance 
the release of arachidonic acid in the presence of either 
AS'P or A23187. In a separate series of  experiments, 
dopamine (0.01-10 aM) did not stimulate inositol 
monophosphat¢ levels in the same cell line. 
Intraeellular calcium concentrations in hD3-GH4C~ 
cells (25 __. 1 riM, n = 10 cells) were likewise unaffected 
/ . ,= 
by perfusion with dopamine ~,0/zM; 24 + 1 nM). Thy- 
rotropin releasing hormone (TRH) has previously been 
shown to increase cytosolic alcium levels in pituitary 
A. Activation 
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1.5] 
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Fig. 3. Whole-cell patch.clamp recording of outward potassium currents inGH4C~ c¢lh. (A) Family of currents elicited by test depolarisations f 
increasing magnitude. Cfi) inactivation el"outw=trd ~arrents by1 s depolarisazioLls prior to the t~s~ d~.polarisation "  +20 m ~r. n-zr = 20 ms. I p.A. 
(C) In tttis c¢11 dopamia¢ caused a <10% increase inthe outward current which was associated (D) with a 6 m'V negative shift in the potential for 
half-maximal activation. The voltage-dependence of inactivation fthe potassium conductance was unaffected. Stippled =;l,Jares, control; filled 
squares, dopamine (10/zM). 
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cells [24] causing an increase in prolactin release. This 
TRH-induced prolactin release can be readily antago- 
nized by activation o f  transfected D., receptors [13]. Fol- 
lowing exposure of the hD3-transfected GHaCt cells to 
TRH (1/~M for 2 min) a mean 43 --. 14% (n = 10) rise 
in intracellular free calcium was observed, but this was 
also unaffected by dopamine (10 ~tM). 
3.3. Characterization of voltage-dependent po assium 
currents and effects of dopamine 
Whole-cell patch-clamp recordings were made from 
44 cells in control and transfected cell lines. GH4C~ cells 
exhibited a mean maximal potassium conductance 
(11 + 1 nS), which was depressed by 44 + 3% with 10 
mM tetraethylammonium ions (n = 3). These currents 
were half-maximally activated at a membrane potential 
of +2 +_. 2 mV (14 cells) and half-maximally inactivated 
with 1 s predepolarising pulses to -39  __. 3 mV (9 cells; 
Fig. 2). 36 __. 5% of the current was resistant to inactiva- 
tion. This observation, coupled to the biphasic inactiva- 
tion curves seen in some ceils, suggests that the macro- 
scopic current arose via activation of  more than one 
type of voltage-dependent K* channel. No effects of 
dopamine (1-10 #M)  were observed in untransfected 
cells. Initial experiments on clone 18 revealed that 
dopamine (10/~M, 2 min) caused a reversible increase 
in the outward current in 2 cells (Fig. 3A). In a third cell 
thi~ was associated with a 6 mV hyperpolarising shift in 
the activation kinetics of this current (Fig. 3B). No ef- 
fects o fdopamine were seen in two other cells from this 
batch or in 25 other cells examined in subsequent exper- 
iments. Thus, unlike rat D,  receptors [15], human D3 
receptors do not couple efficiently to voltage-dependent 
potassium currents in this expression system. 
3.4. Conclusions 
This study describes the stable transfection of GH4C~ 
cells with human D 3 receptors. The paucity of responses 
to dopamine in these transfected cell lines indicates that 
human D3 receptors do not couple efficiently, or at all, 
to second messenger systems which are known to be 
modulated following activation of  D l or  D~ dopamine 
receptor subtypes. Furthermore, these data suggest that 
either the GH4C~ cell line lacks appropriate G-proteins 
to which the receptor may couple, or that the transduc- 
tion mechanism involved is different from that of previ- 
ously described opamine receptors. 
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